Scholarly article on 2-benzylsulfanyl-9H-pyrido[2,3-b]indole 26148-35-6 from Journal of the Chemical Society C: Organic p. 1355,1359

DOI: 10.1039/j39700001355

Source and publish data:

Journal of the Chemical Society C: Organic p. 1355,1359 (1970)

Update date:2022-08-05

Topics:

Authors:

Stephenson

Warburton

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1039/j39700001355

Full text of DOI:10.1039/j39700001355

View Article Online / Journal Homepage / Table of Contents for this issue

View Article Online

Products guided by the article

Product name:2-benzylsulfanyl-9H-pyrido[2,3-b]indole

Cas No:26148-35-6

R&D Labs maybe for 26148-35-6

Shanghai Hohance Chemical Co., ltd

Contact:13914753421

Address:Fl.5；Bld. 70, Lane 1500; Xinfei Road
ZK Biochem Group Co., Ltd

Contact:+86-532-80762375

Address:No. 6, Hongkong Middle Road, Qingdao, China
Improve Medical Technology(Nanxiong) Co., Ltd

Contact:86-751-3836997

Address:No.33, Pingan First Road, Fine Chemical Industry Base, Nanxiong City, Shaoguan, Guangdong, China
ShenZhen InnoSyn Biotech Co.,Ltd

website:http://www.innosyns.com

Contact:+86-755-28351685

Address:Floor 5 & 6, Building A1, HAIKEXING Strategic Innovative Industrial Park, 16 BaoShan Road, PingShan District
Shandong LuZhou Amino Acid Co., Ltd

Contact:86-539-2218025

Address:yishui economic and technical development zone zhenxing south road

Relevant to this article

The synthesis of novel bisphosphonates as inhibitors of phosphoglycerate kinase (3-PGK)

Doi:10.1039/a906507e
(2000)
Niobium- And tantalum-benzamidinato complexes with trimethylphosphine, imido, or η-cyclopentadienyl derivatives

Doi:10.1039/a909333h
(2000)
Electroactive, internal anthraquinonoid dendritic cores

Doi:10.1021/jo991278g
(2000)
Rotaxanes via Michael addition

Doi:10.1021/ol990350u
(2000)
Ring-constrained (N)-methanocarba nucleosides as adenosine receptor agonists: Independent 5′-uronamide and 2′-deoxy modifications

Doi:10.1016/S0960-894X(01)00213-X
(2001)
Synthesis and in vitro anticancer evaluation of 1,4-phenylene-bis-pyrimidine-2-amine derivatives

Doi:10.3906/kim-1603-112
(2017)

Article Doi

DOI: 10.1039/j39700001355